The pathogenesis of familial hypertrophic cardiomyopathy: Early and evolving effects from an α-cardiac myosin heavy chain missense mutation
暂无分享,去创建一个
Dimitrios Georgakopoulos | David A. Kass | D. Kass | J. Seidman | J. G. Seidman | Michael E. Christe | Michael Giewat | Christine M. Seidman | D. Georgakopoulos | M. Christe | M. Giewat | C. Seidman | Michael Giewat
[1] J. Whitworth,et al. Validation of transonic small animal flowmeter for measurement of cardiac output and regional blood flow in the rat. , 1996, Journal of cardiovascular pharmacology.
[2] D. Kass,et al. Marked discordance between dynamic and passive diastolic pressure-volume relations in idiopathic hypertrophic cardiomyopathy. , 1996, Circulation.
[3] J. Seidman,et al. Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. , 1998, The Journal of clinical investigation.
[4] J Ross,et al. Ras-dependent pathways induce obstructive hypertrophy in echo-selected transgenic mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[5] D. Kass,et al. In vivo murine left ventricular pressure-volume relations by miniaturized conductance micromanometry. , 1998, American journal of physiology. Heart and circulatory physiology.
[6] T. Hewett,et al. A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy. , 1998, The Journal of clinical investigation.
[7] Frederick J. Schoen,et al. A Mouse Model of Familial Hypertrophic Cardiomyopathy , 1996, Science.
[8] P. Palatini,et al. Structural abnormalities and not diastolic dysfunction are the earliest left ventricular changes in hypertension. HARVEST Study Group. , 1998, American journal of hypertension.
[9] S. Vatner,et al. Differences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs. , 1996, The Journal of pharmacology and experimental therapeutics.
[10] W. Welch,et al. Validation of miniature ultrasonic transit-time flow probes for measurement of renal blood flow in rats. , 1995, The American journal of physiology.
[11] D. Kass,et al. Mechanism of acute mechanical benefit from VDD pacing in hypertrophied heart: similarity of responses in hypertrophic cardiomyopathy and hypertensive heart disease. , 1998, Circulation.
[12] Michael V. Green,et al. Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: pressure-volume analysis with a nonimaging scintillation probe. , 1983, Circulation.
[13] J. Seidman,et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. , 1992, The New England journal of medicine.
[14] H. Suga,et al. Instantaneous Pressure‐Volume Relationships and Their Ratio in the Excised, Supported Canine Left Ventricle , 1974, Circulation research.
[15] J. Epstein,et al. Hypertrophic cardiomyopathy--beyond the sarcomere. , 1998, The New England journal of medicine.
[16] S. Seto,et al. Impaired left ventricular filling in borderline hypertensive patients without cardiac structural changes. , 1993, American heart journal.
[17] G. Boivin,et al. Overexpression of α1B-adrenergic receptor induces left ventricular dysfunction in the absence of hypertrophy. , 1998, American journal of physiology. Heart and circulatory physiology.
[18] R. Lefkowitz,et al. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. , 1994, Science.
[19] J. Lorenz,et al. Regulatory effects of phospholamban on cardiac function in intact mice. , 1997, American journal of physiology. Heart and circulatory physiology.
[20] M. Entman,et al. Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice. , 1998, The Journal of clinical investigation.
[21] L. Leinwand,et al. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. , 1994, The Journal of biological chemistry.
[22] W. Williams,et al. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. , 1995, Circulation.
[23] R A Milligan,et al. Structure of the actin-myosin complex and its implications for muscle contraction. , 1993, Science.